Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Cited In for PubMed (Select 7564669)

1.

Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.

Ito S, Takao M, Hatsuta H, Kanemaru K, Arai T, Saito Y, Fukayama M, Murayama S.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1714-23. eCollection 2014.

2.

Nonmotor symptoms in a malaysian Parkinson's disease population.

Azmin S, Khairul Anuar AM, Tan HJ, Nafisah WY, Raymond AA, Hanita O, Shah SA, Norlinah MI.

Parkinsons Dis. 2014;2014:472157. doi: 10.1155/2014/472157. Epub 2014 Apr 1.

3.

The dopaminergic system in autoimmune diseases.

Pacheco R, Contreras F, Zouali M.

Front Immunol. 2014 Mar 21;5:117. doi: 10.3389/fimmu.2014.00117. eCollection 2014. Review.

4.

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Dorszewska J, Prendecki M, Oczkowska A, Rozycka A, Lianeri M, Kozubski W.

Curr Genomics. 2013 Dec;14(8):518-33. doi: 10.2174/1389202914666131210210241.

5.

Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.

Farrell KF, Krishnamachari S, Villanueva E, Lou H, Alerte TN, Peet E, Drolet RE, Perez RG.

J Neurochem. 2014 Feb;128(4):536-46. doi: 10.1111/jnc.12481. Epub 2013 Nov 20.

6.

The human gastrointestinal tract, a potential autologous neural stem cell source.

Hagl CI, Heumüller-Klug S, Wink E, Wessel L, Schäfer KH.

PLoS One. 2013 Sep 4;8(9):e72948. doi: 10.1371/journal.pone.0072948. eCollection 2013.

7.

Accumulation of Alpha-synuclein Causes Colonic Dysmotility Independently of Enteric Nervous Damage in the Early Stage of Parkinson's Disease (Neurogastroenterol Motil 2012;24:e425-e436).

Kim YS.

J Neurogastroenterol Motil. 2013 Apr;19(2):264-6. doi: 10.5056/jnm.2013.19.2.264. Epub 2013 Apr 16. No abstract available.

8.

Glutathione metabolism and Parkinson's disease.

Smeyne M, Smeyne RJ.

Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Epub 2013 May 8. Review.

9.

Neurostimulation for neurogenic bowel dysfunction.

Worsøe J, Rasmussen M, Christensen P, Krogh K.

Gastroenterol Res Pract. 2013;2013:563294. doi: 10.1155/2013/563294. Epub 2013 Mar 21.

10.

The pathology roadmap in Parkinson disease.

Surmeier DJ, Sulzer D.

Prion. 2013 Jan-Feb;7(1):85-91. doi: 10.4161/pri.23582. Epub 2013 Jan 1. Review.

11.

Treatment of recurrent sigmoid volvulus in Parkinson's disease by percutaneous endoscopic colostomy.

Toebosch S, Tudyka V, Masclee A, Koek G.

World J Gastroenterol. 2012 Oct 28;18(40):5812-5. doi: 10.3748/wjg.v18.i40.5812.

12.

Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study.

Dobbs RJ, Charlett A, Dobbs SM, Weller C, A Ibrahim MA, Iguodala O, Smee C, Plant JM, Lawson AJ, Taylor D, Bjarnason I.

Gut Pathog. 2012 Oct 19;4(1):12. doi: 10.1186/1757-4749-4-12.

13.

Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss.

Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG.

Acta Neuropathol. 2012 Nov;124(5):665-80. doi: 10.1007/s00401-012-1040-2. Epub 2012 Sep 2.

14.

Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Sulzer D, Surmeier DJ.

Mov Disord. 2013 Jan;28(1):41-50. doi: 10.1002/mds.25095. Epub 2012 Jul 12. Review.

15.

Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Wang L, Magen I, Yuan PQ, Subramaniam SR, Richter F, Chesselet MF, Taché Y.

Neurogastroenterol Motil. 2012 Sep;24(9):e425-36. doi: 10.1111/j.1365-2982.2012.01974.x. Epub 2012 Jul 11.

16.

Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling.

Chalazonitis A, Tang AA, Shang Y, Pham TD, Hsieh I, Setlik W, Gershon MD, Huang EJ.

J Neurosci. 2011 Sep 28;31(39):13746-57. doi: 10.1523/JNEUROSCI.1078-11.2011.

17.

Bladder, bowel, and sexual dysfunction in Parkinson's disease.

Sakakibara R, Kishi M, Ogawa E, Tateno F, Uchiyama T, Yamamoto T, Yamanishi T.

Parkinsons Dis. 2011;2011:924605. doi: 10.4061/2011/924605. Epub 2011 Sep 12.

18.

Constipation in Parkinson's disease.

[No authors listed]

Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S15-6. No abstract available.

19.

Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.

Zhu HC, Zhao J, Luo CY, Li QQ.

J Mol Neurosci. 2012 May;47(1):15-25. doi: 10.1007/s12031-011-9560-0. Epub 2011 Jun 7. Erratum in: J Mol Neurosci. 2012 May;47(1):206.

20.

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.

Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P.

PLoS One. 2010 Sep 14;5(9):e12728. doi: 10.1371/journal.pone.0012728.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk